Van ECK Associates Corp increased its holdings in shares of National Health Investors, Inc. (NYSE:NHI – Free Report) by 10.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,959 shares of the real estate investment trust’s stock after purchasing an additional 767 shares during the period. Van ECK Associates Corp’s holdings in National Health Investors were worth $552,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of NHI. Zimmer Partners LP bought a new position in shares of National Health Investors during the third quarter valued at approximately $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in National Health Investors by 332.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust’s stock valued at $20,370,000 after acquiring an additional 186,238 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in National Health Investors by 17.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock valued at $71,651,000 after acquiring an additional 123,596 shares during the last quarter. Waterfront Capital Partners LLC purchased a new position in shares of National Health Investors in the third quarter worth $10,097,000. Finally, Easterly Investment Partners LLC purchased a new position in shares of National Health Investors in the third quarter worth $5,632,000. 62.51% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Separately, Truist Financial reduced their target price on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a report on Monday, December 23rd. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $76.60.
National Health Investors Stock Down 1.0 %
NHI stock opened at $69.05 on Friday. The firm’s fifty day moving average is $68.62 and its 200 day moving average is $75.12. National Health Investors, Inc. has a one year low of $55.99 and a one year high of $86.13. The firm has a market cap of $3.14 billion, a PE ratio of 23.73, a P/E/G ratio of 4.42 and a beta of 1.06. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- Airline Stocks – Top Airline Stocks to Buy Now
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- DuPont’s Electronics Spinoff: The Start of Something Big
- Using the MarketBeat Dividend Yield Calculator
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI – Free Report).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.